[go: up one dir, main page]

NO20053715D0 - 10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykk - Google Patents

10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykk

Info

Publication number
NO20053715D0
NO20053715D0 NO20053715A NO20053715A NO20053715D0 NO 20053715 D0 NO20053715 D0 NO 20053715D0 NO 20053715 A NO20053715 A NO 20053715A NO 20053715 A NO20053715 A NO 20053715A NO 20053715 D0 NO20053715 D0 NO 20053715D0
Authority
NO
Norway
Prior art keywords
dialkylprostanoic
agents
acid derivatives
intraocular pressure
lowering intraocular
Prior art date
Application number
NO20053715A
Other languages
English (en)
Other versions
NO334659B1 (no
NO20053715L (no
Inventor
Yariv Donde
Jeremiah H Nguyen
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/365,369 external-priority patent/US6875787B2/en
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of NO20053715D0 publication Critical patent/NO20053715D0/no
Publication of NO20053715L publication Critical patent/NO20053715L/no
Publication of NO334659B1 publication Critical patent/NO334659B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/08Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20053715A 2003-02-11 2005-08-01 10,10-dialkylprostanoinsyre-derivater, fremgangsmåte for fremstilling av slike, farmasøytisk produkt omfattende slike samt anvendelse av slike som midler for å senke intraokulært trykk NO334659B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/365,369 US6875787B2 (en) 2003-02-11 2003-02-11 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
US10/772,720 US20040235958A1 (en) 2003-02-11 2004-02-04 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
PCT/US2004/003433 WO2004071428A2 (en) 2003-02-11 2004-02-06 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure

Publications (3)

Publication Number Publication Date
NO20053715D0 true NO20053715D0 (no) 2005-08-01
NO20053715L NO20053715L (no) 2005-10-27
NO334659B1 NO334659B1 (no) 2014-05-12

Family

ID=32871611

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053715A NO334659B1 (no) 2003-02-11 2005-08-01 10,10-dialkylprostanoinsyre-derivater, fremgangsmåte for fremstilling av slike, farmasøytisk produkt omfattende slike samt anvendelse av slike som midler for å senke intraokulært trykk

Country Status (12)

Country Link
EP (1) EP1608309B1 (no)
JP (1) JP5319065B2 (no)
KR (1) KR101077461B1 (no)
AU (1) AU2004211936B2 (no)
BR (1) BRPI0407400A (no)
CA (1) CA2515631C (no)
MX (1) MXPA05008431A (no)
NO (1) NO334659B1 (no)
NZ (1) NZ541352A (no)
PL (1) PL209130B1 (no)
RU (1) RU2336081C2 (no)
WO (1) WO2004071428A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7855226B2 (en) 2003-02-11 2010-12-21 Allergan, Inc. Treatment of inflammatory bowel disease
JP2008518013A (ja) * 2004-10-26 2008-05-29 アラーガン、インコーポレイテッド プロスタグランジンep4アゴニストによる処置方法およびデリバリー方法
AU2012200514B2 (en) * 2005-03-17 2014-03-06 Allergan, Inc. Treatment of inflammatory bowel disease
CN105566192B (zh) * 2006-10-02 2019-01-22 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性的前列腺素及相关化合物的前药
JP5378219B2 (ja) * 2006-10-02 2013-12-25 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ
US8455547B2 (en) * 2008-02-05 2013-06-04 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
US7732443B2 (en) * 2008-03-18 2010-06-08 Yariv Donde Therapeutic substituted cyclopentanes
JP2011519939A (ja) * 2008-05-09 2011-07-14 アラーガン インコーポレイテッド 治療用化合物
EP2488168A1 (en) 2009-10-14 2012-08-22 Gemmus Pharma Inc. Combination therapy treatment for viral infections
RU2013108394A (ru) * 2010-07-30 2014-09-10 Аллерган, Инк. Соединения и способы восстановления кожи
WO2012024376A1 (en) * 2010-08-17 2012-02-23 Allergan, Inc. Ep2 or ep4 agonists for treating corneal haze
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117014A (en) 1976-01-09 1978-09-26 Abbott Laboratories Prostaglandin derivatives
JPS59101458A (ja) * 1982-12-01 1984-06-12 Nippon Iyakuhin Kogyo Kk 新規なチアプロスタグランジン誘導体及びその製法
JPS632972A (ja) * 1986-06-20 1988-01-07 Nippon Iyakuhin Kogyo Kk 新規プロスタグランジンe↓1誘導体及びその製法
US4994274A (en) * 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
US5034413A (en) * 1989-07-27 1991-07-23 Allergan, Inc. Intraocular pressure reducing 9,11-diacyl prostaglandins
US5462968A (en) * 1994-01-19 1995-10-31 Allergan, Inc. EP2 -receptor agonists as agents for lowering intraocular pressure
US5877211A (en) * 1997-11-21 1999-03-02 Allergan EP2 receptor agonists as neuroprotective agents for the eye
US6410591B1 (en) * 2001-05-08 2002-06-25 Allergan Sales, Inc. 3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure
JP4520738B2 (ja) * 2001-06-14 2010-08-11 アラーガン インコーポレイテッド 眼圧降下剤としての3、7、または3および7チアまたはオキサプロスタン酸誘導体

Also Published As

Publication number Publication date
EP1608309B1 (en) 2012-07-11
RU2336081C2 (ru) 2008-10-20
MXPA05008431A (es) 2005-10-19
KR101077461B1 (ko) 2011-10-26
EP1608309A2 (en) 2005-12-28
JP2006517587A (ja) 2006-07-27
RU2005129072A (ru) 2006-02-27
WO2004071428A3 (en) 2005-11-10
AU2004211936A1 (en) 2004-08-26
AU2004211936B2 (en) 2008-09-11
JP5319065B2 (ja) 2013-10-16
NO334659B1 (no) 2014-05-12
CA2515631C (en) 2013-08-20
WO2004071428A2 (en) 2004-08-26
PL209130B1 (pl) 2011-07-29
CA2515631A1 (en) 2004-08-26
BRPI0407400A (pt) 2006-02-21
NZ541352A (en) 2007-12-21
NO20053715L (no) 2005-10-27
KR20050101202A (ko) 2005-10-20
PL378421A1 (pl) 2006-04-03

Similar Documents

Publication Publication Date Title
DK2263674T3 (da) 10,10-Dialkyl-prostansyrederivater som midler til sænkning af intraokulært tryk
NO20041567L (no) 1,8-nafthyridinderivater som antidiabetiske midler
DK1638928T3 (da) N-alkynyl-2-(substituerede aryloxy)alkylthio-amidderivater som fungicider
NO20052993D0 (no) 4,5-diaryltiazolderivater som CB-1 ligander.
DE60314124D1 (de) 2-(2,6-dichlorphenyl)-diarylimidazole
DK1592457T3 (da) Folat-vinblastin-konjugat som lægemiddel
DK1414803T3 (da) Pyrazolylcarboxanilider som fungicider
DK1317431T3 (da) Polyarylcarboxamider, der er anvendelige som lipidsænkende midler
IS8509A (is) Ný 2-heteróarýl-setin bensímídasól afleiða
MX268884B (es) Derivados de merocianina para uso cosmetico.
DK1585749T3 (da) Diazepinoindol-derivater som kinaseinhibitorer
NO20050426L (no) Arylkarbonylderivater som terapeutiske midler
NO20043022L (no) 5,6-diaryl-pyrazin-2-amid-derivater som CB1-antagonister
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
DK1492785T3 (da) 2-hydroxy-3-heteroarylindol-derivater som GSK3-inhibitorer
NO20052884D0 (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
NO20033618L (no) Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
IL181766A0 (en) A process for the preparation of [1,4,5]-oxadiazepine derivatives
AU2003250475A8 (en) 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors
NO20043794L (no) Benzensulfonamidderivater som antipsykotiske midler
DK1575948T3 (da) Pyridodiaziner som plantefungicider
NO20053099D0 (no) Fremgangsmate for a fremstille optisk rene aktive forbindelser.
NO20053715D0 (no) 10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykk
DK1556377T3 (da) Cyclopropylthienylcarboxamider som fungicider
NO20044092L (no) Oftalmisk sammensetning som innbefatter ascomycin

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees